tirzepatide acid reflux Side Effects: Full Guide on Symptoms and Prevention Weight loss journeys aren’t always

7 biggest news story of 2025: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), in widespread use to treat diabetes and obesity, have also demonstrated off-label benefits for a multitude of conditions, including cardiovascular disease, hypertension, Parkinsons, Alzheimers and some addictive disorders

Individual responses to astaxanthin may also differ depending on factors such as skin type, age, and overall health

NICE recommends continuing GLP-1 therapy only if HbA1c reduces by at least 11 mmol/mol and weight decreases by at least 3% at six months

In June 2022, the FDA approved Semaglutide for weight loss

Of the patients currently being treated, women represent nearly 70%